id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2022-E-0249-0004,FDA,FDA-2022-E-0249,Letter to U S Patent and Trademark Office,Other,Letter(s),2022-09-08T04:00:00Z,2022,9,2022-09-08T04:00:00Z,,2022-09-08T16:38:49Z,,0,0,09000064852ce798
FDA-2022-E-0249-0002,FDA,FDA-2022-E-0249,Patent Extension Application from Fish & Richardson P.C. (on behalf of Incyte Corporation),Other,Application,2022-02-28T05:00:00Z,2022,2,2022-02-28T05:00:00Z,,2022-02-28T21:13:19Z,,0,0,0900006484fae04b
FDA-2022-E-0249-0001,FDA,FDA-2022-E-0249,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2022-02-28T05:00:00Z,2022,2,2022-02-28T05:00:00Z,,2022-02-28T21:13:14Z,,0,0,0900006484fae049
FDA-2022-E-0249-0003,FDA,FDA-2022-E-0249,Appendix A-H RE Patent Extension Application from Fish & Richardson P.C. (on behalf of Incyte Corporation),Supporting & Related Material,Background Material,2022-02-28T05:00:00Z,2022,2,,,2022-02-28T21:13:24Z,,0,0,0900006484fae6fb